Cargando…

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer

The availability of blood-based diagnostic testing using a non-invasive technique holds promise for real-time monitoring of disease progression and treatment selection. Circulating tumor cells (CTCs) have been used as a prognostic biomarker for the metastatic breast cancer (MBC). The molecular chara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Zhaomei, Benali-Furet, Naoual, Uzan, Georges, Znaty, Anaëlle, Ye, Zhong, Paolillo, Carmela, Wang, Chun, Austin, Laura, Rossi, Giovanna, Fortina, Paolo, Yang, Hushan, Cristofanilli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085698/ https://www.ncbi.nlm.nih.gov/pubmed/27706044 http://dx.doi.org/10.3390/ijms17101665

Ejemplares similares

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Predictive Value of Circulating Tumor Cells Detected by ISET(®) in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy
por: Garrido Castillo, Laura Nalleli, et al.
Publicado: (2022)

Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples
por: Gogoi, Priya, et al.
Publicado: (2016)

A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
por: Lin, Jianqing, et al.
Publicado: (2016)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
por: Terai, Mizue, et al.
Publicado: (2015)

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
por: Mu, Zhaomei, et al.
Publicado: (2013)

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models
por: Mu, Zhaomei, et al.
Publicado: (2014)

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism
por: Abu-Khalaf, Maysa, et al.
Publicado: (2022)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012)

Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
por: Giuliano, Mario, et al.
Publicado: (2014)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams
por: Serra, Massimo, et al.
Publicado: (2023)

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
por: Cristofanilli, M
Publicado: (2005)

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
por: Mego, M, et al.
Publicado: (2009)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Wang, Chun, et al.
Publicado: (2021)

Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
por: Chong, Weelic, et al.
Publicado: (2021)

Extracellular Matrix Alterations in Metastatic Processes
por: Paolillo, Mayra, et al.
Publicado: (2019)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
por: Visal, Tanvi H., et al.
Publicado: (2022)

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer
por: Rossi, E, et al.
Publicado: (2012)

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
por: Giuliano, Mario, et al.
Publicado: (2011)

Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer
por: Luo, Rui, et al.
Publicado: (2021)

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
por: Mego, Michal, et al.
Publicado: (2012)

Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity
por: Jodon de Villeroché, Vanina, et al.
Publicado: (2010)

A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process
por: Wurth, Roberto, et al.
Publicado: (2015)

Is the rhizosphere a source of applicable multi-beneficial microorganisms for plant enhancement?
por: Chamkhi, Imane, et al.
Publicado: (2022)

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
por: D’Amico, Paolo, et al.
Publicado: (2021)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

Marx y la revolución francesa /
por: Furet, François, 1927-
Publicado: (1992)

Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents
por: Shah, Ami N., et al.
Publicado: (2020)

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
por: Dashzeveg, Nurmaa K., et al.
Publicado: (2023)

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System
por: Cohen, Evan N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bmfg5chjvk33kchdol9rngu1co